Answers are grounded in this paper and cite their sources.
The present article aimed to evaluate the drug therapy applied to patients who were followed up for SARS-CoV-2, and who were tested positive and negative 2019-nCov.
No takes yet. Share an insight, caveat, or question.
Karaarslan et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: